Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

NCT03227419 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

224

Enrollment

OTHER

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Tocilizumab Prefilled Syringe
DRUG: Abatacept Prefilled Syringe

Sponsor

Lille Catholic University